Glenn A. Oclassen
Keine laufenden Positionen mehr
Profil
Glenn A.
Oclassen is the founder of three companies.
He founded Oclassen Pharmaceuticals, Inc. in 1985, NextDerm, Inc. in 1997, and Transcept Pharmaceuticals, Inc. (Old) in 2001.
At Oclassen Pharmaceuticals, Inc., he held the title of Chairman in 1997.
At NextDerm, Inc., he held the title of Chairman, President & Chief Executive Officer in 1999.
At Transcept Pharmaceuticals, Inc. (Old), he held the title of President & Chief Executive Officer in 2009.
Mr. Oclassen's former jobs include being the President & Chief Executive Officer of Transcept Pharma, Inc. from 2009 to 2013, a Director at Novacea, Inc. in 2009, and an Independent Director at Verrica Pharmaceuticals, Inc. from 2015 to 2019.
He was also a Director at Connetics Corp.
and President at Neutrogena Corp.
from 1977 to 1982.
Mr. Oclassen's education history includes an undergraduate degree from San Diego State University in 1965.
Ehemalige bekannte Positionen von Glenn A. Oclassen
| Unternehmen | Position | Ende |
|---|---|---|
North American Clinical Dermatologic Society, Inc.
 North American Clinical Dermatologic Society, Inc. Miscellaneous Commercial ServicesCommercial Services North American Clinical Dermatologic Society, Inc. operates as a non-profit organization which provides clinical dermatology educational opportunities by arranging annual meetings with academic centers and societies worldwide. The company was founded by Charles A. Oclassen in 1959 and is headquartered in Springfield, PA. | Corporate Officer/Principal | 13.11.2019 |
| Cutaneous Therapy Society, Inc. | Corporate Officer/Principal | 13.11.2019 |
| VERRICA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 13.11.2019 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Direktor/Vorstandsmitglied | 06.02.2009 |
Transcept Pharmaceuticals, Inc. (Old)
 Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | Gründer | 01.01.2009 |
Ausbildung von Glenn A. Oclassen
| San Diego State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Neutrogena Corp.
 Neutrogena Corp. Household/Personal CareConsumer Non-Durables Neutrogena Corp. manufactures and markets skin and hair care products. Its products include cleansers, acne, moisturizers, anti-aging, and cosmetics. The company was founded by Emanuel Stolaroff in 1930 and is headquartered in Los Angeles, CA. | Consumer Non-Durables |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Transcept Pharmaceuticals, Inc. (Old)
Transcept Pharmaceuticals, Inc. (Old) Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA. | Health Technology |
Allergan Pharmaceuticals Ltd., Inc.
 Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
Oclassen Pharmaceuticals, Inc.
 Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Health Technology |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Health Technology |
| Dermatology Foundation | |
North American Clinical Dermatologic Society, Inc.
North American Clinical Dermatologic Society, Inc. Miscellaneous Commercial ServicesCommercial Services North American Clinical Dermatologic Society, Inc. operates as a non-profit organization which provides clinical dermatology educational opportunities by arranging annual meetings with academic centers and societies worldwide. The company was founded by Charles A. Oclassen in 1959 and is headquartered in Springfield, PA. | Commercial Services |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
| NextDerm, Inc. | |
| PharmaQuest Corp. | |
| Peachtree Creek Consulting Group | |
| Cutaneous Therapy Society, Inc. |
